Related Experiment Video
Updated: Apr 30, 2026
08:17
Autonomous and Rechargeable Microneurostimulator Endoscopically Implantable into the Submucosa
Published on: September 27, 2018
8.1K
Implantable microchip: the futuristic controlled drug delivery system
Kumar Bishwajit Sutradhar1, Chandra Datta Sumi2
1a Department of Pharmacy , Stamford University , Dhaka , Bangladesh and.
Drug Delivery
|April 25, 2014
Summary
Advanced microchip drug delivery systems offer improved therapeutic efficacy over conventional methods. These MEMS-based devices enhance drug administration, reduce toxicity, and improve patient compliance for better treatment outcomes.
Area of Science:
- Biomedical Engineering
- Materials Science
- Pharmacology
Background:
- Conventional drug delivery systems face limitations including systemic toxicity, narrow therapeutic windows, and complex dosing schedules.
- These limitations hinder therapeutic efficacy and patient compliance in long-term treatments.
- There is a need for advanced drug delivery systems offering enhanced activity and reduced complications.
Purpose of the Study:
- To provide an overview of the feasibility and applications of microchip-based drug delivery systems.
- To explore microchip technology as an advanced alternative to conventional drug delivery.
- To summarize current advancements and research in microchip-controlled drug delivery.
Main Methods:
- Review of investigations on microchip drug delivery systems.
- Summary of micro-fabrication technologies for implantable devices.
- Analysis of commercial manufacturing materials and methods for microchips.
Main Results:
- Microchip-based drug delivery systems, utilizing micro-electrochemical systems (MEMS), demonstrate potential to overcome conventional system limitations.
- Implantable controlled-release microchip devices offer improved drug administration and patient compliance.
- The technology enables enhanced drug delivery with potentially fewer complications.
Conclusions:
- Microchip technology represents a significant advancement in controlled drug delivery.
- These systems hold promise for improving therapeutic outcomes and patient quality of life.
- Further research and development in microchip drug delivery are warranted.
Related Concept Videos
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
172
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
172
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
137
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
137
01:21Intrauterine Drug Delivery Systems
168
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
168
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
177
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
177
01:28Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
208
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
208
01:18Transdermal Drug Delivery Systems
233
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
233